Abstract
Introduction
Human Hepatocellular Carcinoma (HCC) is the most common malignant primary liver tumor [1] , the most serious complication of long-standing chronic liver disease (CLD) and the third cause of cancer-estimated deaths worldwide [2] , symptomatic only at the advanced stage when effective and radical therapies are limited. Thus, a better understanding of the molecular events inducing hepatocyte transformation is of the utmost importance.
Hepatocarcinogenesis is a multistep process in cirrhosis [3] . Hepatocyte neoplastic transformation is associated with hepatocyte proliferation [4] , activation of oncogenes, DNA rearrangement, chromosomal instability [5] , and mitochondrial DNA damage [6] . Thus, selected cell population proliferate with activation of survival pathways inducing malignant phenotype [7, 8] as in the case of apoptotic pathway deregulation [4, 9] . CLD are all characterized by chronic inflammation and increased production of free radicals [10, 11] . Oxidative stress leads to cellular damage and cell function disruption causing hepatocyte death and regeneration [11] therefore increasing liver cell turnover in a context of chronic inflammation and oxidative damage [12] .
APE1/Ref-1 is a master regulator of cellular response to oxidative stress, involved in transcriptional regulation of gene expression during adaptive cellular response to oxidative stress and in base excision repair pathway of oxidative DNA lesions [13] . APE1/Ref-1 is regulated at both the transcriptional and post-translational levels; Reactive Oxygen Species (ROS) induce APE1/Ref-1 expression [14, 15] .
In a previous work we have addressed the functional protective role of APE1/Ref-1 in preventing cell death upon genotoxic treatment and Fatty Acid accumulation using hepatic cell lines [16] . Oxidative damage play a role in inflammation driven carcinogenesis [17, 18] , as in the case of HCC, it facilitates tumorigenesis in several ways [19, 20] by deregulation of preneoplastic and neoplastic cell apoptosis [21, 22] , developing resistance against cell death signaling pathways. Alteration of APE1/Ref-1 intracellular distribution pattern and its up-regulation have been shown to correlate with clinical outcome in different human cancers [23, 24] . We have previously demonstrated that in HCC, APE1/Ref-1 sub-cellular localization have a prognostic significance being its cytoplasmic localization associated with a worst prognosis [25] . However, no data are available about APEX1 gene expression level in human HCC and cirrhotic tissues with respect to normal liver. 
Materials and Methods Patients
Nineteen HCC subjects were consecutively enrolled and treated, six with liver transplantation (OLT) and 13 with liver resection. One liver donor was used as normal control (NL). Sixteen of them were males and three were females with M/F ratio of 5/1 and a mean age of 63±7 years (no differences between sexes). Eight patients were HCV, 5 HBV and 6 alcohol abusers.
Samples of HCC and distal liver cirrhosis (DLC) were obtained at the time of surgery. Formalin fixed and paraffin embedded, 4-μm sections were cut and stained with hematoxylineosin. Cirrhosis was clinically staged by Child-Pugh score [26, 27] 12 being A, 6 B and 1 C. Tumor staging was assessed using BCLC [27] , three were A1, 3 A4, 13 A3. HCC was classified according to Edmondson and Steiner criteria [28] 14 being G1-G2 and 5 G3-G4, analyzed by a single operator. For molecular analysis of APEX1 expression, samples of DLC and HCC collected during the surgery were immediately snap frozen and stored at -80°C until the RNA extraction. All clinical data have been collected at the time of surgery. For each patient a written informed consent form has been obtained. 
Transfections
All transfections were carried out in IHH cells. The sequences of interest were cloned into p3XFLAG-CMV™-14 obtaining 2 different expression vectors with the Flag at the C-terminus: 1) p3XFLAG empty vector used as control (IHH/p3X), 2) pRef-1 containing the cDNA coding for the wild type protein (IHH/pRef-1). Transfection was performed using Lipofectamine 2000 according to the manufacturer's instructions. Selection of stable episomal transfectants has been obtained using G418 antibiotic.
Real Time RT-PCR
Total RNA was extracted using Tri-Reagent kit in accordance with manufacturer's instructions. Quantification and quality evaluation were performed spectrophotometrically being RNA quality criteria sufficed when A260/A280 ratio was between 1.8 and 2.0 and A260/A230 ratio greater than 2.0. 
Nuclear, cytoplasmic and mitochondrial fractionation
Nuclear cytoplasmic and mitochondrial extracts were isolated by differential centrifugation as previously described [35, 36] . Cellular purified fractions were separated on a 10% SDS-PAGE gel and evaluated by Western Blot. APE1/Ref-1 was detected with the same antibody and conditions previously described. To test nuclear and cytoplasmic enrichments anti α-tubulin antibody and anti p84 antibody (Abcam Inc., catalog ab487, 1:1000), have been used as cytoplasmic and nuclear markers respectively.
Immunocytochemistry
IHH, Huh-7 and JHH6 were grown on glass coverslips to reach a 50-60% confluence, fixed with paraformaldehyde 4% and permeabilized with 0.1% Triton X-100, treated with RNAse A and blocked with PBS containing 2.5% FBS. The coverslips were then incubated with the same anti-APE1/Ref-1 primary antibody used for WB, fluorescein isothiocyanate (FITC)-conjugated mouse antibody was used as secondary antibody. Propidium iodide stained the nucleus. Fluorescent images were visualized by Leica DM2000 apparatus, captured by charge-coupled-device camera (Leica DC490) and processed using Adobe Photoshop CS 8.0. Immunocytochemistry was used to access flagged proteins subcellular localization, anti-Flag M2 form Sigma (1:1000) was used to detect flagged APE1/Ref-1, nuclei were stained using Hoechst 33342 and mitochondria were stained using MitoTracker Red CMX ROS.
Western Blot for APE1/Ref-1 transfected forms
Total protein extracts from each clone were separated on a 10% SDS-PAGE gel as previously 
Oxidative stress induction and MTT analysis
IHH/pRef-1and IHH/p3X were plated (25000 cells/cm 2 ) in 24 well tissue culture plates. After 24 hours cells were exposed to hydrogen peroxide at the following concentrations: 0, 100, 150, 200 and 250 μM for additional 24h, and cytotoxicity was tested by MTT reduction assay. Absorbance was measured in a plate reader (Beckman Coulter LD400) at λ = 562 nm.
Induction and detection of apoptosis
Apoptosis was induced by irradiating cells (in fixed volumes of culture medium) at 90 mJ/cm 2 during 12" using a UV Stratalinker 2400 apparatus. To quantify cell death, apoptosis was induced and 6 h after irradiation floating cells and adhering cells were collected and stained with annexin V-FITC and Propidium Iodide (50 μg/mL). Stained cells were then analyzed by flow cytometry using a FACScalibur system (Becton Dickinson). Apoptosis induction was further investigated by evaluating BAX activation and Cytochrome C release by immunocytofluorescence. Cells were stained with mitotracker Red CMX ROS, nuclei were stained by Hoechst 33342. BAX activation was detected using anti-BAX cdc2 antibody (1:200) and Cytochrome C release using anti-Cyt C antibody (1:400) as primary antibodies, anti mouse FITC was used as secondary antibody. Cells were then visualized by Zeiss Axiovert 135TV apparatus; images were captured by Photometric CE200A CCD device camera and processed using Adobe Photoshop CS 8.0. Scoring of BAX Activation and Cytochrome C release was performed by counting at least 100 fluorescent cells per field. Only the cells displaying a clear diffuse cytoplasmic staining for Cytochrome C (cytochrome C release feature) and a clear BAX mitochondrial localization were scored as apoptotic cells. (Fig 1B) with increasing levels moving from DLC to HCC ( Fig 1A) . All showed an up-regulation of APE1/Ref-1 in HCC with HCC/DLC ratio >1 (Fig 1C) , while only 57.8% of subjects presented an up-regulation in cirrhosis as compared to NL (Fig 1C) (Fig 2A) , (Fig 2B) indicating that increased mRNA synthesis is associated with increased APE1/Ref-1 protein production especially in poorly-differentiated hepatoma. In addition to the main band that was observed at the expected 37 kDa corresponding to the APE1/Ref-1 full length protein, a second less intense band of a MW around 33 kDa (Fig 2B) was observed only in the poorly-differentiated hepatoma cell lines. This band is consistent with APE1/Ref-1 truncated form lacking the N-terminal 33 amino acids already described [37] . APE1/Ref-1 was found both in the nucleus and cytoplasm (Fig 3A) . However, Western blot analysis performed on nuclear and cytoplasmic enriched fractions (Fig 3B) showed higher protein content in JHH6 cytoplasmic fraction with respect to Huh-7 and IHH. On the contrary, the relative APE1/Ref-1 nuclear amount was comparable in the 3 cell lines (Fig 3C) . These data confirm the previous observation that APE1/ Ref-1cytoplasmic localization is more frequent in poorly differentiated HCC.
Statistical analysis
To evaluate the possible role of APE1/Ref-1 on hepatocyte survival, an over-expression strategy was used obtaining IHH/p3X and IHH/pRef-1 cells with preserved hepatocyte cell morphology when compared to IHH parental cells. Both the exogenous flagged APE1/Ref-1 (Fig 4A) and the endogenous protein ( Fig 4B) were expressed in the transfected IHH demonstrating that the exogenous APE1/Ref-1 over-expression did not suppress the endogenous protein production. In addition, exogenous APE1/Ref-1 was localized both in IHH nucleus, cytoplasm and mitochondria (Fig 4B) indicating that the intracellular trafficking was not altered either by the FLAG sequence or by the over-expression. When these cells were exposed to oxidative stress, IHH/pRef-1, exerted a significant protection against H 2 O 2 damage than IHH/p3X, at 150, 200 and 250 μM (p<0.05). At higher concentration (350 μM), this protection disappeared (NS) (Fig 5A) . The main difference was found at 250 μM H 2 O 2 with an IHH/p3X viability almost half of that of IHH/pRef-1 (27.0 ± 2.04 vs. 57.91 ± 3.67, respectively; p = 0.022). These findings collectively indicate, as in other cell lines, that increased expression levels of APE1/Ref-1 protect hepatocytes from oxidative stress damage [38] .
Hepatocyte survival ability was studied by inducing apoptosis. Six hours after UV irradiation the number of Annexin V positive cells (Fig 5B) was significantly reduced (p = 0.001) in IHH/pRef-1 than in control cells indicating that APE1/Ref-1 protects hepatocytes from apoptotic stimulus.
Since the inactivation of mitochondrial apoptotic intrinsic pathway is crucial for hepatocyte survival and HCC development, and to further investigate APE1/Ref-1 role in apoptosis escape, we studied BAX activation and Cytochrome C release inhibition. APE1/Ref-1 over-expression (Fig 5C) .
Discussion
APE1/Ref-1 is known to be deregulated in different tumors and this deregulation correlates with tumor aggressiveness and prognosis (39, 40) . In HCC, APE1/Ref-1 cytoplasmic localization is more frequent in poorly-differentiated tumors and is associated with a shorter survival time [25] . However, the mechanism linking the cytoplasmic accumulation with hepatocarcinogenesis is still not known. It has been demonstrated that APE1/Ref-1 cytoplasmic localization enhances lung tumor aggressiveness [39] . Hepatocarcinogenesis begins in cirrhotic hepatocytes [40] where persistent cellular damage induces an increased ROS production [41] . APE1/Ref-1 is a master regulator of cellular response to oxidative stress and it has been demonstrated that its intracellular localization has a prognostic significance also in predicting HCC relapse after transplantation [42] . APE1/Ref-1 over-expression depends in part by NF-kB pathway in cancer cells [43] . [44] and melanoma [45] . It has been demonstrated that both APE1/Ref-1 mRNA levels and protein production are altered in chronic viral hepatitis [46] , and this agrees with our finding that APE1/Ref-1 is up-regulated mostly in cirrhotic tissue of HCV affected patients. Although in the present study APE1/Ref-1 resulted over-expressed in all HCC specimens, more than half of patients showed an up-regulation also in DLC, [48] . This is important since hepatocarcinogenesis is characterized by a progressive de-differentiation of the hepatocytes [28, 28, 49, 49, 50] . This is in line with our finding of a significant increase of APE1/Ref- [51, 52] . ROS play a role in progression of CLD to HCC [9] and activates APE1/Ref-1. In fact, during cellular response to oxidative stress neo-synthesized APE1/Ref-1 is rapidly translocated into the nuclear compartment. Nuclear localization of APE1/Ref-1 is controlled by the first 20 amino acids at the N-terminus sequence through a nuclear localization signal (NLS) [49] . Qu demonstrated that S-nitrosation in response to NO stimulation leads to the nuclear to cytoplasmic APE1/Ref-1 translocation by a nuclear export signal [53, 54] . Thus, both nuclear import and export may control sub-cellular distribution of APE,1 its intracellular trafficking and protein activities. It has been shown both that APE1/Ref-1 up-regulation is associated with an increased cell resistance toward oxidative stress [37] and that APE1-Ref-1 silencing enhances cell sensitivity to radiotherapy [55] . The reduction of APE1/Ref-1 mRNA and protein levels is associated to a reduced cell resistance to death [56] . Here we demonstrated that APE1/Ref-1 over-expression in hepatocytes confers cell survival advantage as an adaptive response to oxidative damage.
We observed that, in IHH, transfection with pRef-1 exert a significant protection both against H 2 O 2 induced oxidative insult and against UV irradiation by reducing the hepatocyte apoptotic rate. It is known that APE1/Ref-1 knockdown sensitizes cells to apoptosis induced by oxidative stress both in vitro [57] and in vivo [58] , that APE1/Ref-1 silencing increases HCC We showed that APE1/Ref-1 over-expression reduce the hepatocyte apoptotic rate pointing to a possible link between APE1/Ref-1 over-expression and hepatocyte survival. Some pro-apoptotic molecules such as BAX are down regulated or inactivated in HCC [59] causing cell survival through mitochondrial apoptotic pathway dysfunction. [60] . Bhattacharyya demonstrated that APE1/Ref-1 expression reduce BAX production and apoptotic rate in Helicobacter pylori-mediated gastric epithelial cell apoptosis [61] . Mitochondrial targeted APE1/ Ref-1 reduced the apoptotic Cytochrome C release [62] and absence of APE1/Ref-1 decreased the ratio of Bcl2/BAX protein expression resulting in Cytochrome C release and apoptosis [57] . In HCC the apoptotic rate is reduced, but, if BAX activation is induced, this apoptotic rate can be reversed [63] suggesting BAX as a potential therapeutic target in HCC. Interestingly, in our model APE1/Ref-1 over-expression was able to inhibit BAX activation and Cytochrome C release, and this is the first report demonstrating that APE1/Ref-1 over-expression may protect human hepatocytes from apoptosis acting at the mitochondrial apoptotic pathway level.
In summary, this study demonstrated for the first time that APE1/Ref-1 synthesis is up-regulated in human hepatocellular carcinoma and that mRNA level increases according to the progression of liver disease. We also showed that APE1/Ref-1 over-expression protects normal hepatocytes from oxidative stress damage and reduce apoptotic rate by inhibiting BAX activation suggesting another APE1/Ref-1 cytoplasmic role in hepatocyte survival. Although all these observation need to be confirmed in a larger cohort of patients, our findings point to APE1/ Ref-1 as a promising molecular target for HCC diagnosis and treatment being implicated in hepatocyte survival and escape from apoptosis.
